Alnylam Pharmaceuticals (ALNY) Net Income (2009 - 2026)
Alnylam Pharmaceuticals (ALNY) posted Net Income of $164.49 million for Q2 2026, compared with -$72.23 million a year earlier and down 20.1% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Net Income (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Income at Alnylam Pharmaceuticals was $774.71 million; for FY2025, it came in at $313.75 million.
- In prior years, Alnylam Pharmaceuticals' Net Income was -$278.16 million in FY2024, -$440.24 million in FY2023, -$1.13 billion in FY2022 and -$852.82 million in FY2021.
- Quarterly Net Income has run from a low of -$405.92 million in Q3 2022 to a high of $292.68 million in Q3 2025 over five years.
- According to Business Quant data, Net Income for the three prior quarters was $205.99 million (Q1 2026), $111.54 million (Q4 2025) and $292.68 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 2.51 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | -237.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Alnylam Pharmaceuticals | 34.23 Bn | 22.28 Bn | 992.69 Mn | 164.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 164.49 Mn |
| Mar 31, 2026 | 205.99 Mn |
| Dec 31, 2025 | 111.54 Mn |
| Sep 30, 2025 | 292.68 Mn |
| Jun 30, 2025 | -72.23 Mn |
| Mar 31, 2025 | -18.25 Mn |
| Dec 31, 2024 | -83.76 Mn |
| Sep 30, 2024 | -111.57 Mn |
| Jun 30, 2024 | -16.89 Mn |
| Mar 31, 2024 | -65.94 Mn |
| Dec 31, 2023 | -137.87 Mn |
| Sep 30, 2023 | 147.75 Mn |
| Jun 30, 2023 | -276.02 Mn |
| Mar 31, 2023 | -174.10 Mn |
| Dec 31, 2022 | -207.49 Mn |
| Sep 30, 2022 | -405.92 Mn |
| Jun 30, 2022 | -277.40 Mn |
| Mar 31, 2022 | -240.34 Mn |
| Dec 31, 2021 | -258.46 Mn |
| Sep 30, 2021 | -204.51 Mn |
API Access
Alnylam Pharmaceuticals Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();